[Retracted] (‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway.
- 1Department of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
- 2Department of Cardiology, Fourth Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Abstract
Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that the control GAPDH western blot data featured in Fig. 4A on p. 8305 had already appeared previously in an article in the journal Cellular Physiology and Biochemistry in a different experimental context written by different authors (albeit one of the research institutes was held in common between the papers). In addition, after assessing the data in this paper independently in the Editorial Office, it also came to light that two pairs of data panels featured respectively in Fig. 2A (showing H&E‑stained histological sections) and Fig. 2B (showing the results of TUNEL assays) contained overlapping sections of data where different experimental conditions were reported, suggesting that these data panels were derived from the same original sources. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. Upon contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 8300‑8308, 2018; DOI: 10.3892/mmr.2018.8870].
Related
- Lysosomal protein transmembrane 5 protects against myocardial ischemia-reperfusion injury by promoting mitophagy via the NEDD4-LC3 axis.
- Blocking MyD88 Signaling Pathway Protects Against Myocardial Ischemia Reperfusion by Inhibiting NOX/ROS Pathway and Enhancing eNOS Activity
- Superior cervical sympathetic ganglionectomy protects against diabetic myocardial ischemia/reperfusion injury via α7nAChR/JAK2/STAT3 signaling pathway
- Inhibition of PCSK9 protects against myocardial ischemia-reperfusion injury by suppressing ferroptosis via negative regulation of the P65/MMP9 pathway
- Activation of skeletal muscle Nrf2 protects the heart against ischemia-reperfusion injury in male mice
BibTeX
@article{li2026retracted,
title = {{[Retracted] (‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway.}},
author = {Jia-Wen Li and Xiao-Yun Wang and Xin Zhang and Lei Gao and Li-Feng Wang and Xin-Hua Yin},
journal = {Molecular medicine reports},
year = {2026},
month = oct,
doi = {10.3892/mmr.2026.14036},
url = {https://europepmc.org/article/MED/42852631},
note = {CC BY},
}
RIS
TY - JOUR
TI - [Retracted] (‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway.
AU - Jia-Wen Li
AU - Xiao-Yun Wang
AU - Xin Zhang
AU - Lei Gao
AU - Li-Feng Wang
AU - Xin-Hua Yin
PY - 2026
DA - 2026/10/09
JO - Molecular medicine reports
DO - 10.3892/mmr.2026.14036
UR - https://europepmc.org/article/MED/42852631
AB - Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that the control GAPDH western blot data featured in Fig. 4A on p. 8305 had already appeared previously in an article in the journal Cellular Physiology and Biochemistry in a different experimental context written by different authors (albeit one of the research institutes was held in common between the papers). In addition, after assessing the data in this paper independently in the Editorial Office, it also came to light that two pairs of data panels featured respectively in Fig. 2A (showing H&E‑stained histological sections) and Fig. 2B (showing the results of TUNEL assays) contained overlapping sections of data where different experimental conditions were reported, suggesting that these data panels were derived from the same original sources. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. Upon contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 8300‑8308, 2018; DOI: 10.3892/mmr.2018.8870].
SN - 1791-2997
SN - 1791-3004
ER -